{"public_id":"cl_6aaaf7f32b374d157d56d61928ae068c","status":"active","superseded_by_public_id":null,"corpus_id":121120559,"text":"Bromocriptine induces apoptosis of prolactinoma cells through the ERK/EGR1 signalling pathway, whereas cabergoline induces autophagic death by inhibiting the AKT/mTOR signalling pathway.","confidence":0.97,"paper":{"corpus_id":121120559,"title":"Bromocriptine and cabergoline induce cell death in prolactinoma cells via the ERK/EGR1 and AKT/mTOR pathway respectively","url":"https://sah.borca.ai/papers/121120559"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.97,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_5dd1fa3d2972734e3516c1461e72f373","name":"bromocriptine","description":"A dopamine agonist used to treat hyperprolactinemia and prolactinoma.","types":["drug"],"url":"https://sah.borca.ai/concepts/co_5dd1fa3d2972734e3516c1461e72f373"},{"public_id":"co_64525426bd6e5cf84213e4c460f9b884","name":"AKT/mTOR signalling pathway","description":"A signaling pathway centered on AKT and mTOR that regulates cell growth and survival.","types":["signalling pathway"],"url":"https://sah.borca.ai/concepts/co_64525426bd6e5cf84213e4c460f9b884"},{"public_id":"co_f90d1c0f7185af829fa403fd5f44cef3","name":"cabergoline","description":"A dopamine agonist used to treat hyperprolactinemia and prolactinoma.","types":["drug"],"url":"https://sah.borca.ai/concepts/co_f90d1c0f7185af829fa403fd5f44cef3"},{"public_id":"co_fa834b3bed0d25d6e6d69ce0bf86c24d","name":"ERK/EGR1 signalling pathway","description":"A signaling cascade involving ERK and EGR1 that regulates cellular responses.","types":["signalling pathway"],"url":"https://sah.borca.ai/concepts/co_fa834b3bed0d25d6e6d69ce0bf86c24d"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_6aaaf7f32b374d157d56d61928ae068c"}